...to 1,500 construction jobs will be created over two years on the back of a building bonanza at several major multinationals.The...
...projects announced will deliver a significant boost for the troubled sector.It maintained that 10 firms need over 1.5m...
BOSTON Scientific is laying off 150 short-term staff after a decision not the renew their contracts with the US multinational.The...
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
Inc. (STJ), a P/E of 19.0 for Abbott Laboratories (ABT) and an industry average of 20.4. While the growth element improves the picture for St. Jude, giving that company a price-to-earnings over growth (PEG) ratio of 1.15, Medtronic is close behind with... Full Article at Seeking Alpha
XIENCE ist eingetragenes Markenzeichen der Abbott Laboratories Unternehmensgruppe. PROMUS ist Handelsname des Everolimus freisetzenden Koronarstentsystems XIENCE-V, das von Abbott hergestellt und von Boston Scientific vertrieben wird. Über die Studie... Full Article at premium presse 5
This undated photo provided by Boston Scientific Corp. , shows Michael Mahoney who will appointed president of Boston Scientific Corp. , Oct. 17, 2011. Boston Scientific Corp.'s choice of Johnson & Johnson executive Michael Mahoney to become its next... View Photo »
This advanced stent is supported by strong clinical outcomes from the PLATINUM trial, which demonstrated very low rates of revascularization and stent thrombosis at one and two years. It is the latest example of Boston Scientific's commitment to market leadership and continued innovation in drug-eluting...
ZMH). All of these firms are becoming more and more dependent on government reimbursements for much of their revenues and are being hurt by cutbacks. For example, Medicare spending now accounts for more two-thirds of US revenue for many device makers. ... Full Article at Motley Fool
A similar situation applies for the current fiscal with 1 upward revision over the past month and none in the negative direction. The upside in estimate revisions, though minor, points towards a gradual improvement in the defibrillator market. This was... Full Article at Zacks Investment Research
Surgeons implant the mesh in patients to strengthen tissue weakened by childbirth or age and to keep the women’s internal organs in place. The first vaginal mesh implant was introduced by Boston Scientific, which received clearance from the FDA to... Full Article at Consumer Reports
The Emerge Catheter builds on Boston Scientific's expertise in developing leading catheter technology and our commitment to offering the most advanced devices to treat coronary artery disease
York, May 21st (TradersHuddle.com) - Shares of Boston Scientific Corporation (NYSE:BSX) ended the trading session lower by $0.12 or -1.89% from its previous close. Boston Scientific's price action formed what is considered to be a bearish engulfing... Full Article at Investopedia
El análisis de los datos ha sido presentado hoy en el programa científico de Euro PCR en París. «Los datos del estudio PLATINUM Full Article at PR Newswire
A look at the day's business stories from media outlets around Boston . massbar 's new report suggests that law school should be more like medical school | http://t.co/aqBOjLwE (link to new report incl.) Boston Scientific gets FDA nod for vascular... Full Article at Boston Business Journal
The Boston Scientific Corporation (NYSE: BSX) (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery,... Full Article At Wikipedia.org
This advanced stent is supported by strong clinical outcomes from the PLATINUM trial, which demonstrated very low rates of revascularization and stent thrombosis at one and two years. It is the latest example of Boston Scientific's commitment to market leadership and continued innovation in drug-eluting...
The Emerge Catheter builds on Boston Scientific's expertise in developing leading catheter technology and our commitment to offering the most advanced devices to treat coronary artery disease
will cost Boston Scientific alone more than $100 million a year in additional taxes. Such a severe increase in tax liability will undoubtedly force us to cut critical R&D; funding and inhibit job creation and retention. … It will inevitably stifle innovation, destroy jobs and thwart patient access to br...
By providing interventional radiologists with a third-generation stent platform supported by strong clinical evidence and innovative features, Boston Scientific continues to deliver industry-leading technologies that enhance patient quality of life
Boston Scientific's moves to work with Vodafone and AT&T signals its awareness that, in connected health, it is not just the device--the network matters. The best device in the world is useless if the network fails
Siamo lieti di unirci al team di Boston Scientific, che ci consentirà sia di ampliare i nostri orizzonti commerciali sia di mettere a disposizione di un maggior numero di pazienti in tutto il mondo, questa terapia di efficacia dimostrata.
Con l'acquisizione della Cameron, beneficeremo di un team di professionisti esperti, pionieri di questa tecnologia innovativa e siamo lieti di accoglierli in Boston Scientific
They've decided to fish ... I think it's a big commitment to the future, and I think it's a strategy to separate Boston Scientific and their new cardiac management division from the crowd.
The acquisition of Cameron Health builds on Boston Scientific's commitment to introducing innovation in the [cardiac rhythm management] space and represents an important part of our strategy to generate top-line revenue and market-share growth
The S-ICD System was designed to eliminate the complications associated with transvenous leads, creating an important new treatment option for patients at risk of sudden cardiac arrest ... We look forward to joining the Boston Scientific team, which will allow us to expand our commercialization efforts ...
With Cameron, we gain a strong, experienced team of professionals who are pioneers in this novel technology, and we are thrilled to welcome them to Boston Scientific
Lumenis is excited to continue its long-time distribution agreement with Boston Scientific, a leader in minimally invasive solutions for the urology market ... Together, we offer urologists and their patients a comprehensive set of cost-effective solutions delivered by highly experienced and knowledgeab...
You’ll have oil rig workers taking pictures of equipment using the higher-resolution camera. Or a Consumer Packaged Goods salesperson doing the same thing inside a supermarket. Or a company like Boston Scientific, which has 4,000 salespeople using iPads. They’ll now be able to show even more detailed me...
Boston Scientific’s first priority is patient safety ... The FDA routinely requires the submission of extensive testing results and scientific data.
This approval marks two important milestones for Boston Scientific
- Uterine_Mesh
19 minutes ago
- jobs77
1 hour ago
Rheinische Post: Kommentar zu Eurobonds http://t.co/fm00EbpZ
- prestigecars 4 hours ago
- JobsIn_Boston
4 hours ago
There are no results for this module.
A fresh, fun site featuring celeb gossip, fashion, beauty, love & sex, and health & fitness.
©Independent.ie Back to top